About Getfast Pharmaceuticals
Getfast Pharmaceuticals is a company based in India founded in 2019. It operates as a B2B. The company has 30 employees. Getfast Pharmaceuticals operates in a competitive market with competitors including Better Health Technologies, zdeer, EarthLite, Shuropody and Lifegaurd, among others.
- Headquarter India
- Employees 30
- SectorsHealthcare
- Website getfast.store
- Social Facebook
- Legal Name Getfast Pharmaceuticals Private Limited
- Date of Incorporation 21 Jul, 2015
- Jurisdiction Bangalore, Karnataka, India
- Annual Revenue₹44.38 Cr
FY 2024 · -18% YoY
- Net Loss-₹2.43 Cr
FY 2024 · -5% margin
- EBITDA-₹2.37 Cr
FY 2024 · -5% margin
- Employee Count30
Associated legal entities of Getfast Pharmaceuticals
Getfast Pharmaceuticals operates through Getfast Pharmaceuticals Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Getfast Pharmaceuticals Private Limited CIN U85110KA2015PTC081715 | Active | 21 Jul 2015 | Bangalore, Karnataka | ₹44.4 Cr | 30 | 2 | View details |
Board of directors of Getfast Pharmaceuticals Private Limited (Getfast Pharmaceuticals)
Getfast Pharmaceuticals Private Limited is the primary company behind Getfast Pharmaceuticals. The board of Getfast Pharmaceuticals Private Limited currently have 2 directors; the longest-serving is Tharahunase Bhargava Venkatasubbarao Gopinatha, appointed in 2021. 7 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Tharahunase Bhargava Venkatasubbarao Gopinatha DIN 06571024 | Director | 21 Sep 2021 | 5 yrs | Getfast Pharmaceuticals Private Limited |
| Kusugolli Manjappa Gowda Vivekananda DIN 06977957 | Director | 23 Sep 2021 | 5 yrs | Getfast Pharmaceuticals Private Limited |
Financials of Getfast Pharmaceuticals
Figures of Getfast Pharmaceuticals Private Limited, the primary company behind Getfast Pharmaceuticals, for FY 2024. Revenue was ₹44.38 Cr (-18% year on year). Net loss was -₹2.43 Cr (-5% margin). EBITDA was -₹2.37 Cr (-5% margin). Revenue has grown at a compounded annual rate of -5% over three years and +2% over five years.
- ₹44.38 CrRevenue · FY 2024 · -18% YoY
- -₹2.43 CrNet loss · -5% margin
- -₹2.37 CrEBITDA · -5% margin
- ₹1 LakhPaid-up capital
- 30Employees (provident fund records)
- -5%Revenue CAGR, 3 years
- +2%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Getfast Pharmaceuticals Private Limited are on its company page.
Detailed financial statements for Getfast Pharmaceuticals
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of Getfast Pharmaceuticals
Getfast Pharmaceuticals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Better Health Technologies, zdeer, EarthLite, Shuropody and Lifegaurd, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| joinbetter.com | 2012 | San Francisco, United States | $27.5M | – | An online pharmacy for healthcare products is operated. | |
| zdeer.com | 2014 | Wuhan, China | $15.28M | – | Electric oral care and personal wellness devices are manufactured. | |
| earthlite.com | 1975 | Vista, United States | – | 101 | An online platform for healthcare and massage products is provided. | |
| shuropody.com | 2006 | Rugby, United Kingdom | $1.5M | 370 | Footcare services and specialist footwear products | |
| lifeguard-med.com | 2010 | Chandigarh, India | – | – | An online platform for healthcare products is provided by Lifegaurd. | |
| flextrapower.com | 2015 | Long Island, United States | $100,000 | – | Graphene-based face masks are supplied for virus protection in consumers. | |
| nrshealthcare.co.uk | 1947 | Leicester, United Kingdom | – | 1,270 | Medical products for older people and disabled people | |
| nureca.com | 2016 | Chandigarh, India | – | 102 | Health and wellness devices are manufactured by Nureca in India. |
Detailed competitors of Getfast Pharmaceuticals
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Similar companies to Getfast Pharmaceuticals
10 companies that operate in the same segment as Getfast Pharmaceuticals (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 215.5 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Getfast Pharmaceuticals
Getfast Pharmaceuticals was founded in 2019.
Getfast Pharmaceuticals is headquartered in India.
Getfast Pharmaceuticals has 30 employees.
The primary company behind Getfast Pharmaceuticals, Getfast Pharmaceuticals Private Limited, reported revenue of ₹44.38 Cr for FY 2024, down 18% year on year.
Getfast Pharmaceuticals, established in 2019, excels in providing healthcare solutions, producing pharmaceutical products, distribution, and medical equipment and medicines. Provides delivery solutions for medical equipment and pharmaceutical medicines. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide.
Getfast Pharmaceuticals's top competitors include Better Health Technologies, Shuropody and Nureca.
Getfast Pharmaceuticals operates through Getfast Pharmaceuticals Private Limited.
The legal entities of Getfast Pharmaceuticals currently have 2 directors, including Tharahunase Bhargava Venkatasubbarao Gopinatha, Kusugolli Manjappa Gowda Vivekananda.